Vancomycin is the most common antibiotic for treatment of MRSA, according to a news release. It is the first time a vancomycin-resistant strain of MRSA has been known to cause a bloodstream infection.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
The strain’s vancomycin resistance originated in the community, rather than the hospital, according to the study. This is potentially problematic because community-associated MRSA is associated with easily transmittable skin infections in people of all ages and health statuses, according to a news release.
More Articles on Infection Control & Clinical Quality:
Level of Drug Resistance Does Not Predict HAI Mortality, Study Finds
12 Million U.S. Adults Misdiagnosed Every Year
Patient Safety Tool: Assessment of Appropriateness of Antibiotics
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
